New Zealand reclassifies low-dose CBD, paving the way for OTC sales by Martin Lane October 17, 2023October 17, 2023 New Zealand’s regulator Medsafe has reclassified low-dose CBD from a prescription-only to a restricted medicine, paving […]
NZ industry calls for urgent review of Medicinal Cannabis Scheme as revenue slumps by Steve Jones October 7, 2021October 14, 2021